Clinical Trial Update: Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing temporally-modulated pulsed radiation therapy to standard radiation therapy for newly diagnosed IDH-wildtype, MGMT-unmethylated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Idh-wildtype
• Glioblastoma Mgmt Unmethylated

Snippet

Sponsor: NRG Oncology | Conditions: Glioblastoma, IDH-Wildtype, MGMT-Unmethylated Glioblastoma | Phase 3 | Status: NOT_YET_RECRUITING